CNTT.Q Stock Overview
CannTrust Holdings Inc. produce y distribuye cannabis medicinal y recreativo en Canadá.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CannTrust Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -99.00% |
| 3 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| CNTT.Q | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -1.8% | -1.0% |
| 1Y | -99.0% | 16.6% | 26.0% |
Rentabilidad frente al sector: CNTT.Q obtuvo unos resultados inferiores a los del sector US Pharmaceuticals , que el año pasado arrojó un rendimiento del -4.4%.
Rentabilidad vs. Mercado: CNTT.Q obtuvo unos resultados inferiores a los del mercado US, que fue del 15.2% el año pasado.
Price Volatility
| CNTT.Q volatility | |
|---|---|
| CNTT.Q Average Weekly Movement | 3,272.6% |
| Pharmaceuticals Industry Average Movement | 9.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: CNTT.Qha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: CNTT.Qha disminuido de 4740% a 4522% en el último año, pero sigue siendo superior al 75% de los valores de US.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Corne Melissen | https://www.canntrust.ca |
CannTrust Holdings Inc. produce y distribuye cannabis medicinal y recreativo en Canadá. Vende cannabis seco y extractos de cannabis a los pacientes médicos. CannTrust Holdings Inc. se constituyó en 2015 y tiene su sede en Vaughan (Canadá).
CannTrust Holdings Inc. Fundamentals Summary
| CNTT.Q fundamental statistics | |
|---|---|
| Market cap | US$141.00 |
| Earnings (TTM) | -US$8.97m |
| Revenue (TTM) | US$40.22m |
0.0x
P/S Ratio0.0x
P/E RatioIs CNTT.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CNTT.Q income statement (TTM) | |
|---|---|
| Revenue | CA$54.66m |
| Cost of Revenue | CA$5.48m |
| Gross Profit | CA$49.18m |
| Other Expenses | CA$61.37m |
| Earnings | -CA$12.19m |
Last Reported Earnings
Mar 31, 2019
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CNTT.Q perform over the long term?
See historical performance and comparison